Valued at $83.1M at its later-stage round, Apr 2026. Nothing has traded since.
- ·Watch Linnaeus Therapeutics: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Linnaeus Therapeutics funding history
8 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Feb 2026 | Seed Round | $5.0M | ▮ | ▮ |
| Aug 2025 | Debt | $1.3M | ▮ | ▮ |
| Aug 2024 | Early Stage VC | $5.8M | ▮ | ▮ |
| Jan 2023 | Seed Round | $3.1M | ▮ | ▮ |
| Jan 2023 | Accelerator/Incubator | — | ▮ | ▮ |
| Aug 2021 | Seed Round | $4.3M | ▮ | ▮ |
| + 2 earlier rounds · a free account shows the full history | ||||
Membership and data by Private Market View
Linnaeus Therapeutics valuation
Linnaeus Therapeutics was valued at $83.1 million at its later-stage round in Apr 2026. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Linnaeus Therapeutics raised?
Linnaeus Therapeutics has raised $35.6 million across 8 recorded rounds since 2018. The largest was a $5.8 million early-stage round in Aug 2024; the most recent was a $5 million seed round in Feb 2026.
Linnaeus Therapeutics has filed 9 Form Ds with the SEC since 2018, most recently in Mar 2026 ($4.8 million sold to 25 investors).
Comparable companies
Comparable drug discovery names by valuation on PrivateMarketView: Indapta Therapeutics ($90 million), Hyku Biosciences ($85 million) and Pangea Bio ($80 million).
How Linnaeus Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Linnaeus Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →
Frequently asked about Linnaeus Therapeutics
- What is Linnaeus Therapeutics worth?
- Linnaeus Therapeutics is valued at $83.1M as of Oct 2026. Valued at $83.1M at its later-stage round, Apr 2026. Nothing has traded since.
- How much has Linnaeus Therapeutics raised?
- Linnaeus Therapeutics has raised $35.6M in total funding across 8 recorded rounds.
- When did Linnaeus Therapeutics last raise?
- Linnaeus Therapeutics last raised in Feb 2026 (Seed Round), raising $5.0M.